Is Intuniv a New Nonstimulant Medication for ADHD?


I've been hearing about Intuniv, a new nonstimulant medication for attention deficit hyperactivity disorder (ADHD). Could it be a good option for my son?

Dr. Larry Silver specializes in treating children with attention deficit disorder (ADHD).

Intuniv is an extended-release formulation of the high-blood pressure medication guanfacine (sold for hypertension under the brand name Tenex) that can be used alone or along with stimulant medications in children ages 6 to 17. It is not a new medication.

We have known for many years that guanfacine may help some children with attention deficit hyperactivity disorder (ADHD), especially those with high levels of impulsivity that cause disruptive behaviors. Many practitioners have prescribed this drug “off-label” for a while. You should ask your doctor if he thinks it would be a good option for your son.

Larry Silver, M.D., is clinical professor of psychiatry at Georgetown Medical Center in Washington, D.C. and director of training in child and adolescent psychiatry at Georgetown University School of Medicine. He is a former acting director and deputy director of the National Institute of Mental Health, as well as the author of Dr. Larry Silver's Advice to Parents on AD/HD and The Misunderstood Child: Understanding and Coping with Your Child's Learning Disabilities.
Copyright © 1998 - 2016 New Hope Media LLC. All rights reserved. Your use of this site is governed by our Terms of Service and Privacy Policy.
ADDitude does not provide medical advice, diagnosis, or treatment. The material on this web site is provided for educational purposes only. See additional information.
New Hope Media, 108 West 39th Street, Suite 805, New York, NY 10018